My Profile

Search abstracts

Lewis Sheiner


2019
Stockholm, Sweden



2018
Montreux, Switzerland

2017
Budapest, Hungary

2016
Lisboa, Portugal

2015
Hersonissos, Crete, Greece

2014
Alicante, Spain

2013
Glasgow, Scotland

2012
Venice, Italy

2011
Athens, Greece

2010
Berlin, Germany

2009
St. Petersburg, Russia

2008
Marseille, France

2007
København, Denmark

2006
Brugge/Bruges, Belgium

2005
Pamplona, Spain

2004
Uppsala, Sweden

2003
Verona, Italy

2002
Paris, France

2001
Basel, Switzerland

2000
Salamanca, Spain

1999
Saintes, France

1998
Wuppertal, Germany

1997
Glasgow, Scotland

1996
Sandwich, UK

1995
Frankfurt, Germany

1994
Greenford, UK

1993
Paris, France

1992
Basel, Switzerland

Search abstracts

Abstract number:
Author:
Title:
Abstracts Contents:
Select a meeting:

author

title

meeting

date

type

Theo Reijmers (1), Claudia Hemmelmann (2), Karl-Walter Sykora (3), Ajay Vora (4), Jochen Kehne (2), Ann-Kristin Möller (2), Joachim Baumgart (2), Jeroen Elassaiss-Schaap (1,5)

Population PK Modelling of Treosulfan in Paediatric Allogeneic Transplant Patients

2018
Montreux
Switzerland

21-2-2018 09:42:56

Poster: Drug/Disease modelling - Paediatrics

Theo Reijmers (1), Stefan Zeiser (1), Marieke van den Dobbelsteen (1), Annalene Nel (2), Jeremy Nuttall (2), Neliëtte van Niekerk (2), Jeroen Elassaiss-Schaap (1,3)

Population PK Modeling of Dapivirine released from Vaginal Rings

2017
Budapest
Hungary

27-2-2017 21:16:30

Poster: Drug/Disease modelling - Other topics

J. G. Coen van Hasselt(1), Jeroen Elassaiss-Schaap(1,2), Anuradha Ramamoorthy(3), Brian M. Sadler(4), Sreeneeranj Kasichayanula(5), Yin Edwards(6), Piet H. van der Graaf(1,7), Lei Zhang(1), John A. Wagner(8)

The proof is in the pee: Population asparagus urinary odor kinetics.

2016
Lisboa
Portugal

21-2-2016 19:38:32

Poster: Drug/Disease modeling - Other topics

W. van den Brink, R. Hartman, M. de Bruin, B. Gonzalez, J. Elassaiss-Schaap, P.H. van der Graaf, T. Hankemeier, E.C.M. de Lange

Finding underlying longitudinal patterns in pharmaco-metabolomics data

2016
Lisboa
Portugal

29-2-2016 09:15:58

Poster: Methodology - New Modelling Approaches

M. Chatterjee*, D.C. Turner*, M. Ahamadi*, Dinesh de Alwis*, J. Elassaiss-Schaap**, T. Freshwater*, R de Greef***, C. Li*, K. Mayawala*, J. Stone*, A. Kondic* (presenting author)

Model-based analysis of the relationship between pembrolizumab exposure and efficacy in patients with melanoma and NSCLC: across indication comparison

2015
Hersonissos, Crete
Greece

16-3-2015 17:38:22

Oral: Clinical Applications

Jeroen Elassaiss-Schaap (1), Andreas Lindauer (1), Alexandre Sostelly (1)#, Malidi Ahamadi (2), Kevin Gergich (3), Peter Kang (3), Dinesh de Alwis (3) and Rik de Greef (1)

Modeling of tumor size reduction patterns in advanced melanoma under treatment with MK-3475, a potent antibody against PD-1

2014
Alicante
Spain

17-3-2014 16:11:22

Oral: Clinical Applications

Lindauer, A (1), Valiathan, C (2), Mehta, K (2), Philips, J (3), DeAlwis, D (1), de Greef, R (1), Elassaiss-Schaap, J (1)

Translational Pharmacokinetic/Pharmacodynamic Model of Tumor Growth Inhibition by the New Anti-PD1 Monoclonal Antibody MK-3475

2014
Alicante
Spain

17-3-2014 16:17:25

Poster: Drug/Disease modeling - Oncology

Malidi Ahamadi (1), Marita Prohn (2), Stefaan Rossenu (2), Jung Hoon Lee (1), Rik de Greef (2), Dinesh de Alwis (1), and Jeroen Elassaiss-Schaap (2)

Population Pharmacokinetics of MK-3475, a human Anti-PD-1 Monoclonal Antibody in patients with progressive locally advanced or metastatic carcinoma, melanoma, and non-small cell lung carcinoma

2014
Alicante
Spain

17-3-2014 17:36:14

Poster: Drug/Disease modeling - Oncology

Lindauer, A (1); Guo, Z (2); Zajic, S (3); Huang, S (2); Mehta, K (4); Kumar, B (3); Elassaiss - Schaap, J (1); Bauer, R (5); Clements, JD (3)

Comparison of NONMEM Estimation Methods in the Application of a Markov-Model for Analyzing Sleep Data

2013
Glasgow
Scotland

15-3-2013 20:26:40

Poster: Estimation Methods

Jeroen Elassaiss-Schaap (1), Bill Knebel (2), Ellen Hulskotte (1) and Rik de Greef (1)

Pharmacokinetic-Pharmacodynamic Modelling & Simulation of Org 52186, a V3 antagonist, in Support of a Challenge Agent Trial Design with dDAVP

2012
Venice
Italy

15-3-2012 17:28:50

Poster: Study Design

D. A. Tatosian (1), J. Z. Peng (2), A. Zandvliet (1), J. Elassaiss – Schaap (1), Ashley Martucci (1), Rajesh Krishna (3), Anya Kauh (4), Gendrano III (5), B. Musser (4)

Strategic comparator modeling and simulation to optimize dose selection for a dose-range finding study

2012
Venice
Italy

15-3-2012 20:46:10

Poster: Study Design

Jeroen Elassaiss-Schaap

Allometric scaling in oncology disease progression from xenograft tumor growth to human non-small-cell lung cancer

2010
Berlin
Germany

15-3-2010 20:47:01

Poster: Applications- Oncology

Jeroen Elassaiss-Schaap and Siem Heisterkamp

Variability as constant coefficient of variation: Can we right two decades in error?

2009
St. Petersburg
Russia

12-3-2009 14:52:21

Poster: Methodology- Other topics

Jeroen Schaap

Interspecies Population Modeling Of Pharmacokinetic Data Available At The End Of Drug Discovery

2007
København
Denmark

8-3-2007 13:35:54

Oral Presentation: Model Building Session

Strougo, A(1), Elassaiss-Schaap, J(2), de Greef, HJMM(2), Drenth, H(1)

Mechanism-based model of the effect of co-administration of exogenous testosterone and progestogens on the hypothalamic-pituitary-gonodal axis in men

2007
København
Denmark

23-3-2007 11:24:03

Oral Presentation: Applications

Jeroen Schaap (1), Stefan Verhoeven (2), Gerard Vogel (3), Martijn Rooseboom (3,4) and Rene van Schaik (2)

Automation of Structural Pharmacokinetic Model Search in NONMEM: Evaluation with Preclinical Datasets

2007
København
Denmark

31-3-2007 00:05:11

Poster: Methodology- Algorithms